Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Melenhorst

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
International Journal of Colorectal Disease|January 11, 2023
Assessing the learning curve of robot-assisted total mesorectal excision: a multicenter study considering procedural safety, pathological safety, and efficiencyT A Burghgraef, D J Sikkenk, R M P H Crolla, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|July 26, 2019
The low anterior resection syndrome in a reference population: prevalence and predictive factors in the NetherlandsM van Heinsbergen, J A G Van der Heijden, L P Stassen, et al.
The New England Journal of Medicine|December 12, 2017
Chimeric Antigen Receptor T Cells in Refractory B-Cell LymphomasStephen J Schuster, Jakub Svoboda, Elise A Chong, et al.
The Lancet. Haematology|January 15, 2016
Alemtuzumab in T-cell large granular lymphocytic leukaemia: interim results from a single-arm, open-label, phase 2 studyBogdan Dumitriu, Sawa Ito, Xingmin Feng, et al.
Science Translational Medicine|September 4, 2015
Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemiaDavid L Porter, Wei-Ting Hwang, Noelle V Frey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2019
Optimizing Chimeric Antigen Receptor T-Cell Therapy for Adults With Acute Lymphoblastic LeukemiaNoelle V Frey, Pamela A Shaw, Elizabeth O Hexner, et al.
The New England Journal of Medicine|October 16, 2014
Chimeric antigen receptor T cells for sustained remissions in leukemiaShannon L Maude, Noelle Frey, Pamela A Shaw, et al.
Science Translational Medicine|May 1, 2015
CMV-specific T cells generated from naïve T cells recognize atypical epitopes and may be protective in vivoPatrick J Hanley, Jan J Melenhorst, Sarah Nikiforow, et al.
Science Translational Medicine|July 21, 2017
A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastomaDonald M O'Rourke, MacLean P Nasrallah, Arati Desai, et al.
Blood|May 12, 2016
Persistence of long-lived plasma cells and humoral immunity in individuals responding to CD19-directed CAR T-cell therapyVijay G Bhoj, Dimitrios Arhontoulis, Gerald Wertheim, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
International Journal of Colorectal Disease|January 11, 2023
Assessing the learning curve of robot-assisted total mesorectal excision: a multicenter study considering procedural safety, pathological safety, and efficiencyT A Burghgraef, D J Sikkenk, R M P H Crolla, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|July 26, 2019
The low anterior resection syndrome in a reference population: prevalence and predictive factors in the NetherlandsM van Heinsbergen, J A G Van der Heijden, L P Stassen, et al.
The New England Journal of Medicine|December 12, 2017
Chimeric Antigen Receptor T Cells in Refractory B-Cell LymphomasStephen J Schuster, Jakub Svoboda, Elise A Chong, et al.
The Lancet. Haematology|January 15, 2016
Alemtuzumab in T-cell large granular lymphocytic leukaemia: interim results from a single-arm, open-label, phase 2 studyBogdan Dumitriu, Sawa Ito, Xingmin Feng, et al.
Science Translational Medicine|September 4, 2015
Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemiaDavid L Porter, Wei-Ting Hwang, Noelle V Frey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2019
Optimizing Chimeric Antigen Receptor T-Cell Therapy for Adults With Acute Lymphoblastic LeukemiaNoelle V Frey, Pamela A Shaw, Elizabeth O Hexner, et al.
The New England Journal of Medicine|October 16, 2014
Chimeric antigen receptor T cells for sustained remissions in leukemiaShannon L Maude, Noelle Frey, Pamela A Shaw, et al.
Science Translational Medicine|May 1, 2015
CMV-specific T cells generated from naïve T cells recognize atypical epitopes and may be protective in vivoPatrick J Hanley, Jan J Melenhorst, Sarah Nikiforow, et al.
Science Translational Medicine|July 21, 2017
A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastomaDonald M O'Rourke, MacLean P Nasrallah, Arati Desai, et al.
Blood|May 12, 2016
Persistence of long-lived plasma cells and humoral immunity in individuals responding to CD19-directed CAR T-cell therapyVijay G Bhoj, Dimitrios Arhontoulis, Gerald Wertheim, et al.
Pageof 8